Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins.
暂无分享,去创建一个
M. Prevost | P. Perrin | N. Tordo | O. Schwartz | H. Rocquigny | H. de Rocquigny | C. Petit | N Tordo | J. Heard | M C Prévost | C. Salaün | A. Bosch | H de Rocquigny | N Desmaris | A Bosch | C Salaün | C Petit | P Perrin | O Schwartz | J M Heard | A. Bosch | N. Desmaris
[1] N. Tordo,et al. Evidence of Two Lyssavirus Phylogroups with Distinct Pathogenicity and Immunogenicity , 2001, Journal of Virology.
[2] A. Kingsman,et al. Stable gene transfer to the nervous system using a non-primate lentiviral vector , 1999, Gene Therapy.
[3] E. Hawrot,et al. Binding of rabies virus to purified Torpedo acetylcholine receptor. , 1986, Brain research.
[4] O. Schwartz,et al. Cytosolic Gag p24 as an Index of Productive Entry of Human Immunodeficiency Virus Type 1 , 1998, Journal of Virology.
[5] R. Ruigrok,et al. Low-pH induced conformational changes in viral fusion proteins: implications for the fusion mechanism. , 1995, The Journal of general virology.
[6] T Friedmann,et al. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[7] C. Robison,et al. The Membrane-Proximal Stem Region of Vesicular Stomatitis Virus G Protein Confers Efficient Virus Assembly , 2000, Journal of Virology.
[8] G. Gosztonyi. Reproduction of lyssaviruses: ultrastructural composition of lyssavirus and functional aspects of pathogenesis. , 1994, Current topics in microbiology and immunology.
[9] G. Ugolini,et al. Propagation of pseudorabies virus in the nervous system of the mouse after intranasal inoculation. , 1994, Virology.
[10] F. Superti,et al. Involvement of gangliosides in rabies virus infection. , 1986, The Journal of general virology.
[11] F. Cosset,et al. Retroviral Vectors Pseudotyped with Lymphocytic Choriomeningitis Virus , 1999, Journal of Virology.
[12] R. Ruigrok,et al. Rabies virus glycoprotein is a trimer , 1992, Virology.
[13] L. Chieco‐Bianchi,et al. Truncation of the human immunodeficiency virus type 1 envelope glycoprotein allows efficient pseudotyping of Moloney murine leukemia virus particles and gene transfer into CD4+ cells , 1997, Journal of virology.
[14] N. Tordo,et al. Cytoplasmic Dynein LC8 Interacts with Lyssavirus Phosphoprotein , 2000, Journal of Virology.
[15] C. Aoki,et al. The earliest events in vesicular stomatitis virus infection of the murine olfactory neuroepithelium and entry of the central nervous system. , 1995, Virology.
[16] T. Friedmann,et al. Separable Mechanisms of Attachment and Cell Uptake during Retrovirus Infection , 2000, Journal of Virology.
[17] F. Gage,et al. In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector , 1996, Science.
[18] D. Littman,et al. Packaging system for rapid production of murine leukemia virus vectors with variable tropism , 1992, Journal of virology.
[19] M. Davisson,et al. Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiency. , 1989, The Journal of clinical investigation.
[20] W. Uckert,et al. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1. , 2000, Virology.
[21] F. Gage,et al. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[22] R. Doolittle,et al. Homology between the glycoproteins of vesicular stomatitis virus and rabies virus , 1982, Journal of virology.
[23] O. Danos,et al. Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic, and polytropic murine leukemia viruses , 1992, Journal of virology.
[24] Hideki Mochizuki,et al. High-Titer Human Immunodeficiency Virus Type 1-Based Vector Systems for Gene Delivery into Nondividing Cells , 1998, Journal of Virology.
[25] M. Sitbon,et al. TM domain swapping of murine leukemia virus and human T-cell leukemia virus envelopes confers different infectious abilities despite similar incorporation into virions , 1996, Journal of virology.
[26] M. Suomalainen,et al. Incorporation of homologous and heterologous proteins into the envelope of Moloney murine leukemia virus , 1994, Journal of virology.
[27] H. Rossmann,et al. Pseudotype Formation of Moloney Murine Leukemia Virus with Sendai Virus Glycoprotein F , 1998, Journal of Virology.
[28] P. Bates,et al. Characterization of Ebola Virus Entry by Using Pseudotyped Viruses: Identification of Receptor-Deficient Cell Lines , 1998, Journal of Virology.
[29] A. Miller,et al. Retrovirus Vectors Bearing Jaagsiekte Sheep Retrovirus Env Transduce Human Cells by Using a New Receptor Localized to Chromosome 3p21.3 , 2000, Journal of Virology.
[30] B. Kieffer,et al. Low‐affinity nerve‐growth factor receptor (P75NTR) can serve as a receptor for rabies virus , 1998, The EMBO journal.
[31] N. Tordo,et al. Structure and expression in baculovirus of the Mokola virus glycoprotein: an efficient recombinant vaccine. , 1993, Virology.
[32] B. Groner,et al. Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles. , 1999, Virology.
[33] D. Lindemann,et al. Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins , 1997, Journal of virology.
[34] C. Aiken. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A , 1997, Journal of virology.
[35] F. Cosset,et al. Incorporation of Fowl Plague Virus Hemagglutinin into Murine Leukemia Virus Particles and Analysis of the Infectivity of the Pseudotyped Retroviruses , 1998, Journal of Virology.
[36] R. Wollmann,et al. CNS gene delivery by retrograde transport of recombinant replication-defective adenoviruses. , 1995, Gene therapy.
[37] M. Schachner,et al. The Neural Cell Adhesion Molecule Is a Receptor for Rabies Virus , 1998, Journal of Virology.
[38] D. Trono,et al. Reversal of pathology in the entire brain of mucopolysaccharidosis type VII mice after lentivirus-mediated gene transfer. , 2000, Human gene therapy.
[39] S. Karlsson,et al. Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[40] L. Chieco‐Bianchi,et al. Pseudotyping of Moloney leukemia virus-based retroviral vectors with simian immunodeficiency virus envelope leads to targeted infection of human CD4+ lymphoid cells , 1998, Gene Therapy.
[41] J. Garcia,et al. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus , 1991, Journal of virology.
[42] B. Davidson,et al. Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors , 2000, Neuroreport.
[43] L Naldini,et al. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector , 1997, Journal of virology.
[44] C. Jallet,et al. Chimeric Lyssavirus Glycoproteins with Increased Immunological Potential , 1999, Journal of Virology.
[45] M. Goldsmith,et al. Distinct Mechanisms of Entry by Envelope Glycoproteins of Marburg and Ebola (Zaire) Viruses , 2000, Journal of virology.
[46] R. Swanstrom,et al. Retrovirus envelope glycoproteins. , 1990, Current topics in microbiology and immunology.
[47] K. Conzelmann,et al. Mokola virus glycoprotein and chimeric proteins can replace rabies virus glycoprotein in the rescue of infectious defective rabies virus particles , 1995, Journal of virology.